Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug could beat virus threat in transplant patients

NCT ID NCT07387367

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 5 times

Summary

This study tests a new drug, brincidofovir, against the current treatment cidofovir for adenovirus infection in children and adults who have had a stem cell transplant. About 180 participants will receive one of the two drugs intravenously until the virus is cleared or up to 12 weeks. The goal is to see which drug works better and is safer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Brincidofovir (IV) and cidofovir (IV)
What this could lead to
If brincidofovir works better or is safer than cidofovir, it could become a preferred treatment for adenovirus infections in stem cell transplant patients.
What could go wrong
This is an early Phase 3 trial with only 180 participants, so results may not apply to all patients. Both drugs can cause kidney or liver side effects, and brincidofovir may not prove superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 months and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male and female, post-allo HCT within last 180 days, aged 2 months and older at time of signing informed consent form. 2. Subject/Guardian willing and able to understand and provide written informed consent to participate in the study. 3. In the investigator's judgement, the subject's clinical condition justifies treatment with IV BCV or IV CDV for AdV infection. 4. Has adenoviremia, based on any of: * AdV viremia DNA ≥10,000 IU/mL, OR * Two consecutive and rising AdV viremia DNA results of ≥1,000 IU/mL at screening, OR * AdV viremia DNA of ≥1,000 IU/mL, AND 1\. Lymphocyte count \<180/mm3, OR 2. Received T cell depletion, cord blood, or haploidentical transplant, OR 3. prior alemtuzumab, OR 4. anti-thymocyte globulin (ATG) Exclusion Criteria: 1. Subject received an allo-HCT with a matched sibling donor 2. Subject received more than 5 mg/kg of CDV for any reason in the 21 days prior to first dose of study drug. 3. Subject is allergic or hypersensitive to IV BCV or IV CDV or any of their components. 4. Subject received anti-AdV-specific cell-based therapy within 3 weeks prior to W1D1 or an anti-AdV vaccine at any time. 5. Subject has participated in any other investigational study within 30 days (or within 5.5 half-lives of the investigational product, whichever is longer) before signing the informed consent form (ICF), is currently participating in another interventional treatment trial with an investigational agent or is using an investigational device at the time of Screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenovirus infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    81 sites in 13 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Alberta Children's Hospital University of Calgary

    NOT_YET_RECRUITING

    Calgary, Canada

  • Ann and Robert H Lurie Children's Hospital

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Birmingham Women's and Children's Hospital

    NOT_YET_RECRUITING

    Birmingham, United Kingdom

  • CHU Sainte Justine Hospital

    RECRUITING

    Montreal, Canada

  • Centre Hospitalier Régional Universitaire de Nancy (CHRU) - Hopitaux de Brabois - Hôpital d'enfants

    NOT_YET_RECRUITING

    Nancy, France

  • Centre Hospitalier Universitaire (CHU) de Bordeaux - Hôpital Pellegrin

    NOT_YET_RECRUITING

    Bordeaux, France

  • Centre Hospitalier Universitaire (CHU) de Liège

    NOT_YET_RECRUITING

    Liège, Belgium

  • Centre Hospitalier Universitaire (CHU) de Nantes - Hôpital Mère-Enfants

    NOT_YET_RECRUITING

    Nantes, France

  • Centre Hospitalier Universitaire (CHU) de Rennes - Hôpital Sud

    NOT_YET_RECRUITING

    Rennes, France

  • Charité University Hospital

    NOT_YET_RECRUITING

    Berlin, Germany

  • Children's Healthcare of Atlanta

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • Children's Hospital Colorado-Center for Cancer and Blood Disorders

    NOT_YET_RECRUITING

    Aurora, Colorado, 80045, United States

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Children's National Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Cincinnati Children's Hospital

    RECRUITING

    Cincinnati, Ohio, 45229, United States

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

  • Clinica Universidad de Navarra

    RECRUITING

    Pamplona, Spain

  • Cohen Children's Medical Center

    RECRUITING

    New Hyde Park, New York, 11042, United States

  • Columbia University Irving Medical Center

    NOT_YET_RECRUITING

    New York, New York, 10032, United States

  • Dana-Farber Cancer Institute-Brighman and Women's

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    RECRUITING

    Boston, Massachusetts, 02139, United States

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Essen University Hospital

    RECRUITING

    Essen, Germany

  • Fondazione IRCCS Policlinico San Matteo

    NOT_YET_RECRUITING

    Pavia, Italy

  • Fred Hutchinson Cancer Center

    NOT_YET_RECRUITING

    Seattle, Washington, 98109, United States

  • Great Ormond Street Hospital for Children

    NOT_YET_RECRUITING

    London, United Kingdom

  • Helen Devos Children's Hospital / Michigan State University

    NOT_YET_RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Hopital Jeanne de Flandre

    NOT_YET_RECRUITING

    Lille, France

  • Hopital Maisonneuve-Rosemont - CIUSSS de l Est de L Ile de Montreal

    NOT_YET_RECRUITING

    Montreal, Quebec Province, Canada

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, Spain

  • Hospital Universitario de Salamanca

    NOT_YET_RECRUITING

    Salamanca, Spain

  • Hôpital Saint-Louis

    NOT_YET_RECRUITING

    Paris, France

  • Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre

    NOT_YET_RECRUITING

    Strasbourg, France

  • IRCCS San Raffaele Hospital

    NOT_YET_RECRUITING

    San Raffaele, Italy

  • Instituto Português de Oncologia de Lisboa (IPO Lisboa) Francisco Gentil, EPE

    NOT_YET_RECRUITING

    Lisbon, Portugal

  • Instituto Português de Oncologia do Porto (IPO Porto) Francisco Gentil, EPE

    NOT_YET_RECRUITING

    Porto, Portugal

  • Istituto Giannina Gaslini

    RECRUITING

    Genova, Italy

  • Johns Hopkins All Children's Hospital

    NOT_YET_RECRUITING

    St. Petersburg, Florida, 33701, United States

  • Joseph M Sanzari Children's Hospital

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Karolinska University Hospital

    NOT_YET_RECRUITING

    Stockholm, Sweden

  • Kinderheilkunde I | Universitätsklinikum Tübingen

    NOT_YET_RECRUITING

    Tübingen, Germany

  • Leeds Teaching Hospitals NHS Trust

    RECRUITING

    Leeds, United Kingdom

  • Leiden Unviversity Medical Center

    NOT_YET_RECRUITING

    Leiden, Netherlands

  • Leuven, University Hospital Gasthuisberg

    NOT_YET_RECRUITING

    Leuven, Belgium

  • Medical College of Wisconsin / Children's Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Medizinische Hochschule Hannover

    NOT_YET_RECRUITING

    Hanover, Germany

  • Montreal Children's Hospital - McGill University Health Centre

    NOT_YET_RECRUITING

    Montreal, Quebec Province, Canada

  • Nationwide Children's Hospital

    NOT_YET_RECRUITING

    Columbus, Ohio, 43205, United States

  • Necker Hospital

    NOT_YET_RECRUITING

    Paris, France

  • Ospedale Pediatrico Bambino Gesu'

    RECRUITING

    Rome, Italy

  • Perugia Hospital

    RECRUITING

    Perugia, Italy

  • Phoenix Children's Hospital

    RECRUITING

    Phoenix, Arizona, 85016, United States

  • Princess Maxima Center & UMC Utrecht

    NOT_YET_RECRUITING

    Utrecht, Netherlands

  • Rady Children's Hospital

    NOT_YET_RECRUITING

    San Diego, California, 92123, United States

  • Rigshospitalet

    NOT_YET_RECRUITING

    Copenhagen, Denmark

  • Riley Children's Health (Indiana University)

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Robert-Debré Hospital, APHP Nord Université de Paris Cité.

    RECRUITING

    Paris, France

  • Royal Manchester Children's Hospital

    RECRUITING

    Manchester, United Kingdom

  • Royal Marsden Hospital

    NOT_YET_RECRUITING

    Sutton, United Kingdom

  • Seattle Children's Hospital

    RECRUITING

    Seattle, Washington, 98105, United States

  • Sheffield Children's Hospital

    RECRUITING

    Sheffield, United Kingdom

  • St Louis Children's Hospital - Barnes Jewish Hospital

    RECRUITING

    St Louis, Missouri, 63110, United States

  • St. Anna Kinderspital- Childrens Hospital

    NOT_YET_RECRUITING

    Vienna, Austria

  • St. Jude Children's Research Hospital

    RECRUITING

    Memphis, Tennessee, 38105, United States

  • Stanford Medicine Children's Health

    NOT_YET_RECRUITING

    Palo Alto, California, 94304, United States

  • The Hospital for Sick Children

    RECRUITING

    Toronto, Canada

  • The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital

    RECRUITING

    Newcastle upon Tyne, United Kingdom

  • UT Southwestern Medical Center

    NOT_YET_RECRUITING

    Dallas, Texas, 75390, United States

  • University Children's Hospital

    NOT_YET_RECRUITING

    Münster, Germany

  • University College London Hospitals NHS Foundation Trust

    RECRUITING

    London, United Kingdom

  • University Health Network- Princess Margaret Cancer Centre

    NOT_YET_RECRUITING

    Toronto, Ontario Province, Canada

  • University Hospital Frankfurt, am Main

    RECRUITING

    Frankfurt, Germany

  • University Medical Center Freiburg

    NOT_YET_RECRUITING

    Freiburg im Breisgau, Germany

  • University Medical Center Hamburg-Eppendorf (UKE)

    NOT_YET_RECRUITING

    Hamburg, Germany

  • University of California Davis

    RECRUITING

    Sacramento, California, 95616, United States

  • University of Chicago

    NOT_YET_RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Minnesota

    NOT_YET_RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • University of Nebraska

    RECRUITING

    Omaha, Nebraska, 68182, United States

  • University of Pittsburgh Medical Center Children's Hospital

    NOT_YET_RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Vall d'Hebron University Hospital

    NOT_YET_RECRUITING

    Barcelona, Spain

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.